Effect of treatment delay, age, and stroke severity on the effects of intravenous thrombolysis with alteplase for acute ischaemic stroke: a meta-analysis of individual patient data from randomised trials
Top Cited Papers
Open Access
- 5 August 2014
- journal article
- research article
- Published by Elsevier in The Lancet
- Vol. 384 (9958), 1929-1935
- https://doi.org/10.1016/s0140-6736(14)60584-5
Abstract
No abstract availableKeywords
Funding Information
- Medical Research Council
- British Heart Foundation
This publication has 28 references indexed in Scilit:
- Details of a Prospective Protocol for a Collaborative Meta-Analysis of Individual Participant Data from all Randomized Trials of Intravenous rt-PA vs. Control: Statistical Analysis Plan for the Stroke Thrombolysis Trialists' Collaborative Meta-AnalysisInternational Journal of Stroke, 2013
- The benefits and harms of intravenous thrombolysis with recombinant tissue plasminogen activator within 6 h of acute ischaemic stroke (the third international stroke trial [IST-3]): a randomised controlled trialThe Lancet, 2012
- Recombinant tissue plasminogen activator for acute ischaemic stroke: an updated systematic review and meta-analysisThe Lancet, 2012
- Influence of Age on Outcome From Thrombolysis in Acute StrokeStroke, 2010
- Intravenous Alteplase for Stroke in Those Older Than 80 Years OldStroke, 2010
- Intravenous Thrombolysis Plus Hypothermia for Acute Treatment of Ischemic Stroke (ICTuS-L)Stroke, 2010
- Generalized Efficacy of t-PA for Acute StrokeStroke, 1997
- Tissue Plasminogen Activator for Acute Ischemic StrokeNew England Journal of Medicine, 1995
- Pilot randomized trial of tissue plasminogen activator in acute ischemic stroke. The TPA Bridging Study Group.Stroke, 1993
- Partial residuals for the proportional hazards regression modelBiometrika, 1982